Johnson & Johnson buys medical equipment maker Synthes

    It’s official. Johnson & Johnson will buy medical equipment maker Synthes for $21.3 billion – that’s $181.30 per share. This is J&J’s largest deal ever, and gives the company a chance to be a big name in the trauma market, as the New York Times reports.

    The bid breaks down to 55.65 francs in cash and 103.35 francs worth of Johnson & Johnson common stock — 22 percent premium over Synthes’ April 14 trading before the deal was announced.

    Want a digest of WHYY’s programs, events & stories? Sign up for our weekly newsletter.

    It will take 126,000 members this year for great news and programs to thrive. Help us get to 100% of the goal.